Charlotte's Web and Edibles.com Team up to Protect Consumer Access and Shape Hemp's Future
Rhea-AI Summary
Charlotte's Web (OTCQX: CWBHF) announced a strategic partnership with Edibles.com to expand consumer access to its hemp wellness products via Edibles.com's online marketplace and flagship Atlanta store. The curated assortment includes hemp extracts for sleep, focus, and everyday wellness, functional mushroom products, and a topical cream.
According to Charlotte's Web, the collaboration also supports industry efforts to secure federal standards for non-intoxicating hemp as a potential hemp ban approaches on November 12, 2026. Both companies are urging Congress to extend recriminalization measures and finalize a framework for hemp-derived products, following a U.S. Senate Continuing Resolution that would allow sales through December 11, 2026 if fully approved.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The partnership expands access to trusted hemp wellness products while calling for commonsense federal standards that protect consumers and preserve responsible access
Louisville, Colorado--(Newsfile Corp. - August 25, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), a market leader in hemp wellness, and Edibles.com, a premier retailer and online marketplace, announced a strategic partnership to expand consumer access to trusted hemp wellness products. The partnership also signals a growing alignment in the hemp industry as a potential hemp ban approaches in November.
Beyond the commercial engagement, the companies are jointly urging Congress to act before the November 12, 2026, deadline by redefining non-intoxicating hemp or extending the pending recriminalization measures set to take effect this fall. The request comes as momentum builds in Washington around bipartisan efforts to secure an extension while lawmakers negotiate federal standards for hemp-derived products.
Most recently, on Aug. 8, the U.S. Senate passed a Continuing Resolution (CR) that includes a 30-day extension allowing the sale of naturally derived hemp products through December 11, 2026. If approved by the House and signed by the President, the measure would provide Congress with additional time to finalize a targeted framework and ultimately a comprehensive regulatory solution for hemp-derived products.
Until then, consumers can now shop a curated selection of Charlotte's Web's best-selling products through the Edibles.com marketplace and at its flagship retail location in Atlanta. The assortment includes hemp extract products designed to support sleep, focus, and everyday wellness, along with functional mushroom offerings formulated to help maintain focus, manage stress, and support energy, as well as a topical cream for targeted relief.
More than a marketplace launch, the partnership reflects a broader evolution within the hemp industry. Responsible operators are increasingly aligned around the belief that consumer protection, product quality, regulatory clarity, and continued access can coexist for ingestible and topical products. Consumer demand continues to underscore the importance of passing commonsense legislation.
According to Brightfield Group,
Both Charlotte's Web and Edibles.com have built their businesses around a simple principle: health, not high. Together, the companies are demonstrating what a responsible hemp marketplace can look like, one grounded in transparency, compliance, safety, and consumer trust.
"The conversation has evolved," said Thomas Winstanley, president of Edibles.com. "The industry is no longer debating whether guardrails are needed. We're helping define what those guardrails should look like. Consumer safety, product quality, accountability, and access can coexist. For years, the industry has promoted self-regulation, and now those conversations are being had in earnest. Congress is faced with a choice that impacts an American-made industry that reaches people across the country, including farmers, veterans, older adults, entrepreneurs, and everyday consumers."
Founded on a commitment to quality, compliance, and transparency, Edibles.com has built its marketplace around trusted brands and standards that reflect the future they want to see for consumer protections. Adding Charlotte's Web products to the marketplace brings together two companies committed to advancing the industry's next chapter through responsible leadership and higher standards.
"This partnership is more than a business deal. It's a signal of where the American hemp industry is headed," said Bill Morachnick, Chief Executive Officer of Charlotte's Web. "Our customers are parents, professionals, caregivers, and active adults seeking trusted wellness options, not intoxication. For too long, responsible companies and consumers have paid the price for a market without clear rules. We're now witnessing a fundamental shift toward higher standards and greater accountability. Charlotte's Web's presence on Edibles.com proves that the future of hemp will be built by reputable brands, not regulatory gray areas. We urge Congress to seize the opportunity to bring transparency and pragmatism to the industry while preserving safe access for everyday Americans for generations to come."
Together, Charlotte's Web and Edibles.com are urging the House of Representatives to vote in favor of extending the November ban when Congress returns to the Capital in September. This will allow lawmakers time to redefine non-intoxicating therapeutic hemp products and turn bipartisan progress into lasting policy that protects consumers, rewards responsible operators, and provides long-term certainty for the hemp industry.
Charlotte's Web Holdings, Inc.
Charlotte's Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is a botanical wellness innovation company and a market leader in hemp extract wellness that includes Charlotte's Web whole-plant full-spectrum CBD extracts as well as broad-spectrum CBD and cannabinoid isolates. The Company's hemp extracts have naturally occurring botanical compounds including cannabidiol ("CBD"), CBN, CBC, CBG, THC, terpenes, flavonoids, and other beneficial compounds. Charlotte's Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery, immunity), CBN gummies, hemp-derived THC microdose gummies, functional mushroom gummies, CBD capsules, CBD topical creams, and lotions, as well as CBD pet products for dogs. Through its substantially vertically integrated business model, Charlotte's Web maintains stringent control over product quality and consistency with analytic testing from soil to shelf for quality assurance. Charlotte's Web products are distributed to retailers and healthcare practitioners throughout the U.S.A. and are available online through the Company's website at www.charlottesweb.com.
Shares of Charlotte's Web trade on the TSX under the symbol "CWEB" and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol "CWBHF". Subscribe to Charlotte's Web investor news.
About Edibles.com™
Edibles.com™ is a first-of-its-kind, wellness-driven online marketplace delivering the nation's leading THC brands directly to your door. Designed around efficacy and outcomes, the platform offers high-quality products for every type of consumer—seamlessly integrating e-commerce, industry-leading logistics, and an expanding retail presence. By building a trusted ecosystem for plant-based wellness, Edibles.com is redefining accessibility and convenience in the hemp-THC space. Learn more at www.Edibles.com.
Media Contacts:
Charlotte's Web
AM PR Communications
cw@ampublicrelations.com
Edibles.com
KCSA Strategic Communications
edibles@kcsa.com
Forward-Looking Statements
Certain information provided herein constitutes forward-looking statements or information (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking statements are typically identified by words such as "may," "will," "should," "could," "anticipate," "expect," "project," "estimate," "forecast," "plan," "intend," "target," "believe" and similar words suggesting future outcomes or statements regarding an outlook. Forward-looking statements are not guarantees of future performance and readers are cautioned against placing undue reliance on forward-looking statements. This press release includes forward-looking statements including: the future performance or achievements of DeFloria, Inc.; future clinical trial results, therapeutic efficacy, or regulatory approvals of AJA001 oral solution; the anticipated effects of changes in the regulatory environment, including the reclassification of cannabis to Schedule III; and the continuing relationship between the Company and DeFloria, the results of which may be materially different from those expressed or implied by the forward-looking statements contained in this press release.
By their nature, these statements involve a variety of assumptions, known and unknown risks and uncertainties, and other factors which may cause actual results, levels of activity, and achievements to differ materially from those expressed or implied by such statements. The forward-looking statements contained in this press release are based on certain assumptions and analysis by management of the Company in light of its experience and perception of historical trends, current conditions and expected future developments and other factors that management believes are appropriate and reasonable.
The material factors and assumptions used to develop the forward-looking statements herein include, but are not limited to: regulatory regime changes; anticipated product development and sales; the success of sales and marketing activities; product development and production expectations; outcomes from R&D activities; the Company's ability to deal with adverse growing conditions in a timely and cost-effective manner; the availability of qualified and cost-effective human resources; compliance with contractual and regulatory obligations and requirements; availability of adequate liquidity and capital to support operations and business plans; and expectations around consumer product demand. In addition, the forward-looking statements are subject to risks and uncertainties pertaining to, among other things: supply and distribution chains; the market for the Company's products; revenue fluctuations; regulatory changes; loss of customers and retail partners; retention and availability of talent; competing products; share price volatility; loss of proprietary information; product acceptance; internet and system infrastructure functionality; information technology security; available capital to fund operations and business plans; crop risk; economic and political considerations; and including but not limited to those risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ending December 31, 2025, and other risk factors contained in other filings with the Securities and Exchange Commission available at http://www.sec.gov and filings with Canadian securities regulatory authorities available at www.sedarplus.ca. The impact of any one risk, uncertainty, or factor on a particular forward-looking statement is not determinable with certainty as these are interdependent, and the Company's future course of action depends on management's assessment of all information available at the relevant time.
Any forward-looking statement in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. Except as required by applicable law, the Company assumes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. All forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company's behalf, are expressly qualified in their entirety by these cautionary statements.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/310975